Back
ACNAP Premium Access

Discontinuation of drug treatment due to side effects after first-time percutaneous coronary intervention: a patient perspective.

Session: Oral abstract session - Doctoral Students
Topic: Pharmacotherapy
Speaker: Doctor T. Pettersen (Bergen, NO)
Event: EuroHeartCare 2018

Congress Presentation

Add to my library

Like

About the speaker

Doctor Trond Roed Pettersen

Haukeland University Hospital, Bergen (Norway)
6 presentations
0 follower

7 more presentations in this session

Symptoms of anxiety and depression after percutaneous coronary intervention with comparison to a reference population

Speaker: Mrs S. Olsen (Harstad, NO)

Access
Abstract
Like
Thumbnail

Double trouble: Implications for care and self-management interventions when patients experience type 2 diabetes post-acute coronary syndrome - qualitative study of the patient's perspective

Speaker: Mr M. Tanash (Zarqa, JO)

Access
Abstract
Like
Thumbnail

Readmission and differences in self-reported health and lifestyle factors after heart valve surgery

Speaker: Miss B. Borregaard (Odense, DK)

Access
Abstract
Slides
Like
Thumbnail

Home based cardioversion in the Netherlands

Speaker: Mr G. Hengstman (Maastricht, NL)

Access
Abstract
Slides
Like
Thumbnail

The effectiveness of an avatar-based education application on knowledge and response to heart attack symptoms-A pragmatic randomised trial in patients with acute coronary syndrome

Speaker: Miss J. Tongpeth (Bedford Park, AU)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Oral abstract session - Doctoral Students

Speakers: Doctor T. Pettersen, Mrs S. Olsen, Mr M. Tanash, Miss B. Borregaard, Mr G. Hengstman...
Access
Like
Thumbnail

About the event

Image

EuroHeartCare 2018

7 June - 9 June 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources